Amundi Procept Bio Robotics Corp Transaction History
Amundi
- $264 Billion
- Q3 2024
A detailed history of Amundi transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Amundi holds 19,960 shares of PRCT stock, worth $1.37 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,960
Previous 21,702
8.03%
Holding current value
$1.37 Million
Previous $1.33 Million
20.6%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding PRCT
# of Institutions
271Shares Held
38.7MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$331 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$238 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$105 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$85.1 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$80.7 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.05B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...